Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials
The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Aims Self-monitoring of blood glucose (SMBG) represented a major breakthrough in the treatment of type 1 diabetes. The aim of the present meta-analysis is to assess the effect of continues glucose monitoring (CGM) and flash glucose monitoring (FGM), on glycemic control in type 1 diabetes. Materials and methods The present analysis includes randomized clinical trials comparing CGM or FGM with SMBG, with a duration of at least 12 weeks, identified in Medline or clinicaltrials.gov. The principal endpoint was HbA1c at the end of the trial. A secondary endpoint was severe hypoglycemia. Mean and 95% confidence intervals for HbA1c and Mantel-Haenzel odds ratio [MH-OR] for severe hypoglycemia were calculated, using random effect models. A sensitivity analysis was performed using fixed effect models. In addition, the following secondary endpoints were explored, using the same methods: time in range, health-related quality of life, and treatment satisfaction. Separate analyses were performed for trials comparing CGM with SMBG, and those comparing CGM + CSII and SMBG + MDI and CGM-regulated insulin infusion system (CRIS) and CSII + SMBG. Results CGM was associated with a significantly lower HbA1c at endpoint in comparison with SMBG (- 0.24 [- 0.34, - 0.13]%); CGM was associated with a significantly lower risk of severe hypoglycemia than SMBG. Treatment satisfaction and quality of life were not measured, or not reported, in the majority of studies. FGM showed a significant reduction in t…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two reviews [23, 34] evaluated the effect of CGM versus SMBG on DKA risk, with no statistically significant differences observed between intervention and control groups.”
From Effectiveness of Wearable Devices for Diabetes Management: An Overview of Systematic Reviews and Meta‐Analyses (2026) · cites this paper as [34]
In the citing paper
“Regarding DKA prevention, no significant differences have been observed between intervention and control groups [23, 34]”
From Effectiveness of Wearable Devices for Diabetes Management: An Overview of Systematic Reviews and Meta‐Analyses (2026) · cites this paper as [34]
In the citing paper
“Despite the several RCTs demonstrating benefits of various CGM technologies, uncertainty has persisted regarding their comparative effectiveness across different outcomes, patient subgroups, and technology types [40,41].”
From Effectiveness of continuous glucose monitoring systems on glycemic control in adults with type 1 diabetes: A systematic review and meta-analysis (2025) · cites this paper as [40]
In the citing paper
“However, while the use of CGM systems has been shown to (further) improve therapy for people with T1DM [12, 13], mixed results have been reported on the use of CGM systems by people with T2DM [14, 15].”
From Self-Monitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus (2022) · cites this paper as [12]
In the citing paper
“A lot of clinical [ 4 , 5 ] and real-world studies [ 6 ], as well as systematic reviews and meta-analyses [ 7 , 8 ], have clearly proven the beneficial effect of CGM on glycemic control optimization.”
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667 · cited 1×
“Frequent self-monitoring was one of the key components of intensified diabetes therapy in the Diabetes Control and Complication Trial, which warranted a relevant reduction in long-term complications of diabetes [1].”
BackgroundGRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · cited 2×
“Only two trials with a duration of at least 12 weeks compared a CRIS with SMBG + CSII [13, 39].”
MethodLiberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237 · cited 2×
“The wider use of CGM devices prompted also the introduction of new potential parameters for the assessment of glucose control, such as glycemic variability (often expressed as coefficient of variation or mean amplitude of glucose excursions), and time in range [9].”
BackgroundState of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
Foster, N. C., Beck, R. W., Miller, K. M., Clements, M. A., Rickels, M. R., DiMeglio, L. A., Maahs, D. M., Tamborlane, W. V., Bergenstal, R., Smith, E., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0384 · Cited by 1,907
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Lind, M., Polonsky, W., Hirsch, I. B., Heise, T., Bolinder, J., Dahlqvist, S., Schwarz, E., Ólafsdóttir, A. F., Frid, A., Wedel, H., et al. (2017) · JAMA · doi:10.1001/jama.2016.19976 · Cited by 705
Haak, T., Hanaire, H., Ajjan, R., Hermanns, N., Riveline, J.-P., & Rayman, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-016-0223-6 · Cited by 623 · cited 1×
“Notably, FGM did not reduce HbA1c in patients with type 2 diabetes on basal-bolus insulin therapy, despite higher baseline HbA1c values [48], whereas CGM improved glycemic control in patients with similar characteristics [49].”
Background
Cited by
Teo, E., Hassan, N., Tam, W., & Koh, S. (2022) · Diabetologia · doi:10.1007/s00125-021-05648-4 · Cited by 186
Elbalshy, M., Haszard, J., Smith, H., Kuroko, S., Galland, B., Oliver, N., Shah, V., de Bock, M. I., & Wheeler, B. J. (2022) · Diabetic Medicine · doi:10.1111/dme.14854 · Cited by 104
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring
Tauschmann, M., Forlenza, G., Hood, K., Cardona‐Hernandez, R., Giani, E., Hendrieckx, C., DeSalvo, D. J., Laffel, L. M., Saboo, B., Wheeler, B. J., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13451 · Cited by 100
New advances in type 1 diabetes
Subramanian, S., Khan, F., & Hirsch, I. B. (2024) · BMJ · doi:10.1136/bmj-2023-075681 · Cited by 88
Di Molfetta, S., Di Gioia, L., Caruso, I., Cignarelli, A., Green, S. C., Natale, P., Strippoli, G. F. M., Sorice, G. P., Perrini, S., Natalicchio, A., et al. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3842 · Cited by 76
Riveline, J.-P., Roussel, R., Vicaut, E., de Pouvourville, G., Detournay, B., Emery, C., Levrat-Guillen, F., & Guerci, B. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0085 · Cited by 64
Pleus, S., Freckmann, G., Schauer, S., Heinemann, L., Ziegler, R., Ji, L., Mohan, V., Calliari, L. E., & Hinzmann, R. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01254-8 · Cited by 55
“%) have T2DM; the remaining PwD have various forms of diabetes, including T1DM, gestational diabetes mellitus, fibrocalculous pancreatic diabetes, among other forms [48].”
BackgroundInfluentialVisser, M. M., Charleer, S., Fieuws, S., Block, C. E. M. D., Hilbrands, R., Huffel, L. V., Maes, T., Vanhaverbeke, G., Dirinck, E. L., Myngheer, N., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00352-7 · Cited by 63
Tauschmann, M., Cardona‐Hernandez, R., DeSalvo, D. J., Hood, K. K., Лаптев, Д. Н., Olinder, A. L., Wheeler, B. J., & Smart, C. E. (2025) · Hormone Research in Paediatrics · doi:10.1159/000543156 · Cited by 82
Richardson, K. M., Jospe, M. R., Bohlen, L. C., Crawshaw, J., Saleh, A. A., & Schembre, S. M. (2024) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-024-01692-6 · Cited by 57
Aggarwal, A., Pathak, S., & Goyal, R. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109825 · Cited by 55
Kong, A. P. S., Lim, S. K., Yoo, S.-H., Ji, L., Chen, L., Bao, Y., Yeoh, E. C. K., Chan, S.-P., Wang, C., Mohan, V., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110718 · Cited by 49
Current Management of Glycemia in Children with Type 1 Diabetes Mellitus
Sperling, M. A., & Laffel, L. M. (2022) · New England Journal of Medicine · doi:10.1056/nejmcp2112175 · Cited by 43
Low carbohydrate high fat ketogenic diets on the exercise crossover point and glucose homeostasis
Noakes, T. D., Prins, P. J., Volek, J. S., D’Agostino, D. P., & Koutnik, A. P. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1150265 · Cited by 33
T1DiabetesGranada: a longitudinal multi-modal dataset of type 1 diabetes mellitus
Rodriguez-León, C., Avilés-Pérez, M. D., Baños, O., Quesada‐Charneco, M., Lopez-Ibarra, P. J., Villalonga, C., & Muñoz‐Torres, M. (2023) · Scientific Data · doi:10.1038/s41597-023-02737-4 · Cited by 43
Molfetta, S. D., Caruso, I., Cignarelli, A., Natalicchio, A., Perrini, S., Laviola, L., & Giorgino, F. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14981 · Cited by 36
Manov, A. E., Chauhan, S., Dhillon, G. S., Dhaliwal, A., Antonio, S., Donepudi, A., Jalal, Y., Nazha, J., Banal, M., & House, J. (2023) · Cureus · doi:10.7759/cureus.42545 · Cited by 48
Ahn, J., Yang, Y., & Park, G. (2024) · Geriatric Nursing · doi:10.1016/j.gerinurse.2024.06.041 · Cited by 38
Price, C. E., Fanelli, J. E., Aloi, J., Anzola, S. C., Vishneski, S. R., Saha, A. K., Woody, C., & Segal, S. (2023) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2023.111090 · Cited by 32
Boscari, F., Vettoretti, M., Cavallin, F., Amato, A. M. L., Uliana, A., Vallone, V., Avogaro, A., Facchinetti, A., & Bruttomesso, D. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01624-2 · Cited by 33
Overcoming the Limitations of Stem Cell-Derived Beta Cells
Karimova, M. V., Gvazava, I. G., & Vorotelyak, E. A. (2022) · Biomolecules · doi:10.3390/biom12060810 · Cited by 35
Been, R. A., Lameijer, A., Gans, R. O. B., van Beek, A. P., Kingsnorth, A. P., Choudhary, P., & van Dijk, P. R. (2024) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188241236289 · Cited by 31
Chang, V. Y. X., Tan, Y., Ang, W. H. D., & Lau, Y. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109192 · Cited by 32
Kang, H. S., Park, H. R., Kim, C., & Singh‐Carlson, S. (2022) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106221116899 · Cited by 31
Continuous Glucose Monitoring in Dogs and Cats
Baldo, F. D., & Fracassi, F. (2023) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2023.01.008 · Cited by 26
Cho, S. H., Kim, S., Lee, Y., Jin, S., Hur, K. Y., Kim, G., & Kim, J. H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1165471 · Cited by 29
Applying technologies to simplify strategies for exercise in type 1 diabetes
Perkins, B. A., Turner, L. V., & Riddell, M. C. (2024) · Diabetologia · doi:10.1007/s00125-024-06229-x · Cited by 25
Madsen, K. P., Olsen, K. R., Rytter, K., Willaing, I., Pedersen‐Bjergaard, U., Schmidt, S., Nørgaard, K., & Kjær, T. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110225 · Cited by 24
Read, M., Henshaw, K., Zaharieva, D. P., Brown, T. C., Varga, A. E., Bray, C., Cox, M., Goody-Rohdin, P.-J., Hider, K., Jelleyman, P., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110830 · Cited by 20
The emerging role of digital health in the management of asthma
Kaplan, A. G., Boivin, M. R., Bouchard, J., Kim, J., Hayes, S. W., & Licskai, C. J. (2023) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223231209329 · Cited by 27
Oriot, P., & Hermans, M. P. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108385 · Cited by 21
Sebastián‐Valles, F., Alfonso, J. M., Martín, J. A. A., Jiménez‐Díaz, J., Alday, I. H., Navas-Moreno, V., Joya, T. A., García, M. D. M. F., Gómez, G. L. R., Lobariñas, L. E. L., et al. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02204-x · Cited by 19
Boscari, F., Ferretto, S., Cavallin, F., Fadini, G. P., Avogaro, A., & Bruttomesso, D. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01884-1 · Cited by 22
Préau, Y., Galie, S., Schaepelynck, P., Armand, M., & Raccah, D. (2021) · Sensors · doi:10.3390/s21186131 · Cited by 20
Sehgal, S., de Bock, M. I., Williman, J. A., Taylor, B. J., Elbalshy, M. M., Galland, B. C., Hall, R. M., Paul, R. G., Boucsein, A., Jones, S., et al. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00923-y · Cited by 16
Duarte, D. B., Fonseca, L., Santos, T., Silva, V. B., Puga, F. M., Saraiva, M., Silva, I., Teixeira, S., Vilaverde, J., & Cardoso, M. H. (2022) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2022.102509 · Cited by 16
Lega, I. C., Yale, J.-F., Chadha, A., Paty, B., Roscoe, R., Snider, M., Steier, J., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.08.003 · Cited by 12
Kinny, F., Schlottau, S., Sherazi, B. A., Obarcanin, E., & Läer, S. (2024) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2024.100465 · Cited by 18
Changes in A1C Versus GMI Across Glycemic Categories in Clinical Trials of Type 1 Diabetes
Montaser, E., Abad, S. E., & Shah, V. N. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf211 · Cited by 12
Noor, N., Norman, G. J., Sonabend, R., Chao, L. C., Kamboj, M. K., Golden, L., Bekx, M. T., Hseih, S., Levy, C. J., Sanchez, J. E., et al. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231178017 · Cited by 15
Alfadli, S. F., Alotaibi, Y. S., Aqdi, M. J., Almozan, L. A., Alzubaidi, Z. B., Altemani, H. A., Almutairi, S. D., Alabdullah, H. A., Almehmadi, A. A., Alanzi, A. L., et al. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100382 · Cited by 16
Pylov, D., Polonsky, W. H., Imberg, H., Holmer, H., Hellman, J., Wijkman, M. O., Bolinder, J., Heise, T., Dahlqvist, S., Nyström, T., et al. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231183974 · Cited by 15
Ridder, F. D., Braspenning, R., Ordóñez, J., Klarenbeek, G., Lauwers, P., Ledeganck, K. J., Delbeke, D., & Block, C. E. M. D. (2024) · PLoS ONE · doi:10.1371/journal.pone.0301041 · Cited by 13
Riddell, M. C., Shakeri, D., & Scott, S. N. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0427 · Cited by 11
Gupta, A. V., Mukherjee, S., Bhadada, S. K., Ram, S., Pal, R., Sachdeva, N. K., & Dutta, P. R. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111610 · Cited by 10
Rytter, K., Madsen, K. P., Andersen, H. U., Cleal, B. R., Hommel, E. E., Nexø, M. A., Pedersen‐Bjergaard, U., Skinner, T. C., Willaing, I., Nørgaard, K., et al. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01181-0 · Cited by 12
Molfetta, S. D., Rossi, A., Assaloni, R., Cherubini, V., Consoli, A., Bartolo, P. D., Guardasole, V., Laurenzi, A., Lombardo, F., Maffeis, C., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109867 · Cited by 13
Gao, Y., Zhou, M., Xu, X., & Chen, W. Y. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108314 · Cited by 13
Exercise and Self-Management in Adults with Type 1 Diabetes
McCarthy, M. M., Ilkowitz, J. T., Zheng, Y., & Dickson, V. V. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01707-3 · Cited by 13
Giza, S., Kotanidou, E. P., Tsinopoulou, V. R., Poukoulidou, T., Ntouma, S., & Galli-Tsinopoulou, A. (2025) · Children · doi:10.3390/children12121668 · Cited by 7
“A lot of clinical [4,5] and real-world studies [6], as well as systematic reviews and meta-analyses [7,8], have clearly proven the beneficial effect of CGM on glycemic control optimization.”
Criteria for Personalised Choice of a Continuous Glucose Monitoring System: An Expert Opinion
Molfetta, S. D., Rossi, A., Boscari, F., Irace, C., Laviola, L., & Bruttomesso, D. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01654-y · Cited by 7
Molfetta, S. D., Rossi, A., Gesuita, R., Faragalli, A., Cutruzzolà, A., Irace, C., Minuto, N., Pitocco, D., Cardella, F., Arnaldi, C., et al. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02381-3 · Cited by 7
Hayek, A. A., Mashali, M. A., & Dawish, M. A. A. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01569-w · Cited by 7
Rohner, D. G., Burget, L., Henzen, C., & Fischli, S. (2024) · Swiss Medical Weekly · doi:10.57187/s.3366 · Cited by 6
The practical operation and consequences of glucose measurement by pilots with diabetes
Fan, K. S., Manoli, A., Shojaee‐Moradie, F., Hutchison, E. J., Strollo, F., Koehler, G., Mader, J. K., & Russell-Jones, D. L. (2024) · Diabetic Medicine · doi:10.1111/dme.15472 · Cited by 6
Visser, M. M., Muylder, A. V., Charleer, S., Isitt, J. J., Roze, S., Block, C. E. M. D., Maes, T., Vanhaverbeke, G., Nobels, F. R. E., Keymeulen, B., et al. (2024) · Diabetologia · doi:10.1007/s00125-023-06084-2 · Cited by 6
Bone, J., Leach, C., Addala, A., & Amed, S. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0366 · Cited by 4
de Jong, L. A., Li, X., Emamipour, S., van der Werf, S., Postma, M. J., van Dijk, P. R., & Feenstra, T. (2024) · PharmacoEconomics · doi:10.1007/s40273-024-01388-6 · Cited by 6
Flash Glucose Monitoring Systems in Pediatric Populations With Diabetes
Young, C. J., & Grobelna, A. (2021) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2021.60 · Cited by 4
Jensen, M. H., Cichosz, S. L., Gustenhoff, P., Nikontovic, A., Hejlesen, O. K., & Vestergaard, P. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274626 · Cited by 7
Lee, M. J., Seo, B.-J., & Cho, J. (2025) · Life · doi:10.3390/life15101543 · Cited by 5
Ståhl, F. L., Hellman, J., & Ekelund, C. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251414976 · Cited by 4
Larson, R., Philbrick, A. M., Carlin, C., & Harris, I. M. (2023) · Journal of Pharmacy Technology · doi:10.1177/87551225231194027 · Cited by 4
Technologies and emerging trends in wearable biosensing
Ganatra, S., Bhanushali, N., Kosare, S., Barot, H., & Pandya, A. (2025) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2025.06.011 · Cited by 3
Real-Time Continuous Glucose Monitoring for People Living With Type 1 Diabetes
Barbara, A. M., & Grobelna, A. (2022) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2022.419 · Cited by 2
Yeşil, F., & Özçelik, Ç. Ç. (2024) · Balkan Medical Journal · doi:10.4274/balkanmedj.galenos.2024.2024-2-115 · Cited by 9
Du, Y., Baumert, J. J., Buchmann, M., Holl, R. W., & Heidemann, C. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0623 · Cited by 2
Dicembrini, I., Poggi, C. D., Vescovo, G. G. D., Marinelli, C., Scoccimarro, D., Vitale, V., Silverii, G. A., Drigani, L., Pancani, F., Norgiolini, R., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70511 · Cited by 2
Self-citationAmpudia‐Blasco, F. J., Ugarte, E., Chico, A. I., García-Alemán, J., & Galan-Barroso, M. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221087270 · Cited by 3
Artificial intelligence in critically ill diabetic patients: current status and future prospects
Juneja, D., Gupta, A., & Singh, O. (2022) · Artificial Intelligence in Gastroenterology · doi:10.35712/aig.v3.i2.66 · Cited by 3
de Jong, L. A., Li, X., Emamipour, S., van der Werf, S., Postma, M. J., van Dijk, P. R., & Feenstra, T. (2023) · PharmacoEconomics - Open · doi:10.1007/s41669-023-00428-9 · Cited by 2
Takaike, H., Miura, J., Hoshina, S., Takagi, S., Takita, M., Mochizuki, S., & Babazono, T. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110890 · Cited by 2
Present and Future of Research on Continuous Glucose Monitoring: A Narrative Review
Ahn, J., Kang, J. H., Pahn, J., & Yang, Y. (2023) · Korean Journal of Adult Nursing · doi:10.7475/kjan.2023.35.4.311 · Cited by 2
Shi, Y., Qin, J., Li, Y., Yang, J., & Lü, Y. (2024) · Metabolites · doi:10.3390/metabo14110644 · Cited by 3
Type 1 diabetes in children: adulthood ahead
Лаптев, Д. Н. (2025) · Diabetes Mellitus · doi:10.14341/dm13252 · Cited by 4
Diabetic ketoacidosis due to a sensor defect of FreeStyle Libre: A case report
Kogai, T., Sato, J., Hirakata, M., Iwamoto, T., Nakajima, K., Goto, H., Nishida, Y., & Watada, H. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14065 · Cited by 1
Improving School Nurse Confidence With Continuous Glucose Monitoring Technology
Seiler, S., & McClanahan, R. (2025) · NASN School Nurse · doi:10.1177/1942602x251341902 · Cited by 1
Therapie des Typ-1-Diabetes: Kurzfassung der S3-Leitlinie. Version 5.0, AWMF-Registernummer: 057-013
Haak, T., Fritsche, A., Füchtenbusch, M., Gehr, B., Gölz, S., Kröger, J., Siegmund, T., Ziegler, R., Droßel, D., Fuchs, S., et al. (2025) · Diabetologie und Stoffwechsel · doi:10.1055/a-2592-7826 · Cited by 2
Alabdulkarim, H. A., Al-Shraim, M., Motahari-Nezhad, H., Fgaier, M., Péntek, M., Gulàcsi, L., Aldahash, R., & Zrubka, Z. (2026) · Journal of Diabetes Science and Technology · doi:10.1177/19322968261445111 · Cited by 1
Dei, A., Aldigeri, R., Bellei, G., Raffaeli, D., Bartolo, P. D., Sforza, A., Marchesini, G., Ciardullo, A. V., Manicardi, V., Bianco, M., et al. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02298-x · Cited by 2
Navrátilová, V., Zadáková, E., Šoupal, J., Škrha, J., Do, Q. D., Radovnická, L., Hašková, A., Prázný, M., & Horová, E. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70047 · Cited by 2
van Dijk, P. R., Lommerde, N., Fokkert, M. J., Edens, M. A., Hernández, A. D., Delgado, E., Slingerland, R. J., & Bilo, H. J. G. (2022) · Research Square · doi:10.21203/rs.3.rs-1319932/v1 · Cited by 1
Continuous glucose monitoring and hypoglycaemia events: unmet needs
Papaioannou, T. G., Sanoudou, D., & Tsioufis, C. (2022) · Diabetologia · doi:10.1007/s00125-022-05739-w · Cited by 1
Talaiti, M., Liao, X., Abulimiti, N., Zeng, M., & Wang, Y. (2026) · Journal of Diabetes Research · doi:10.1155/jdr/1464982
New perspectives on real-time continuous glucose monitoring
Štechová, K. (2021) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30393-x
Egmose, J., Sørensen, K. H., Holm, T. F., Hejlesen, O. K., Jensen, M. H., & Hangaard, S. (2022) · Linköping electronic conference proceedings · doi:10.3384/ecp187010
Il monitoraggio in continuo della glicemia: stato dell’arte
Irace, C., & Molfetta, S. D. (2022) · il Diabete · doi:10.30682/ildia2204g · Cited by 1
Trends in Time in Range–Related Publications and Clinical Trials: A Bibliometric Review
Patel, P. M., Abaniel, R. M., Dogra, N., Lo, C. B., Frazzitta, M. A., & Virdi, N. S. (2023) · doi:10.2337/figshare.22714573.v1
Trends in Time in Range–Related Publications and Clinical Trials: A Bibliometric Review
Patel, P. M., Abaniel, R. M., Dogra, N., Lo, C. B., Frazzitta, M. A., & Virdi, N. S. (2023) · doi:10.2337/figshare.22714573
Perfilando la tecnología en diabetes
Gómez, N. B., Jiménez-Salazar, S., Delgado, M. R., Botero, J. F., & Rincón, A. R. (2024) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.11.1.852
Lameijer, A. (2024) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.1021051970
Rutkowska, K., Łoś-Stegienta, A., Baginski, M., Zięba, E., Baran, A., Żurawska-Kliś, M., Kosiński, M., & Cypryk, K. (2024) · Diagnostics · doi:10.3390/diagnostics14161777
Application of Data Science in Management of Type 1 Diabetes
Meng, W., Qin, J., Wang, T., & Zhao, R. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1009379
Glucose meters and sensors for type 1 diabetes (part 2)
Slee, P. H. T. J., Helmerhorst, F. M., & Nieuwhof, M. (2023) · Geneesmiddelenbulletin · doi:10.35351/gebu.2023.6.10 · Cited by 2
Strumenti per valutare l’aderenza al trattamento insulinico nel diabete mellito
Gioia, L. D., Caporusso, M., Iacobone, C., Molfetta, S. D., Laviola, L., & Giorgino, F. (2025) · L Endocrinologo · doi:10.1007/s40619-025-01645-6
Garabédian, C., Sénat, M., Sananès, N., Berveiller, P., Brillac, T., Lous, M. L., Lemaître, M., Mitanchez, D., Morel, O., Paquin, S., et al. (2025) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2025.12.001 · Cited by 1
Umehara, T., Aoyama, T., Fujimura, R., Takahashi, A., Arai, S., Tonezawa, S., Hagiwara, R., Morimoto, J., Funazaki, S., Yamada, H., et al. (2025) · Diabetes Technology and Obesity Medicine · doi:10.1177/29986702251409796
Therapie des Typ-1-Diabetes: Kurzfassung der S3-Leitlinie. Version 5.0, AWMF-Registernummer: 057-013
Haak, T., Fritsche, A., Füchtenbusch, M., Gehr, B., Gölz, S., Kröger, J., Siegmund, T., Ziegler, R., Droßel, D., Fuchs, S., et al. (2026) · Die Diabetologie · doi:10.1007/s11428-026-01467-6
Hjortdahl, F. J., Årsand, E., & Joakimsen, R. M. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02297-9
Alghafri, T. S., Harthi, S. A., Ishaq, A. B., AlHarthi, H., Muaini, M. A., Al-Ghadani, R., (, A. A., AlHarb, M., AlSaadi, A., Abdesselam, A., et al. (2026) · JMIR Research Protocols · doi:10.2196/99626
Metadata
- Authors
- Dicembrini, I., Cosentino, C., Monami, M., Mannucci, E., & Pala, L.
- Affiliations
- Azienda Ospedaliero-Universitaria Careggi (IT)
- Corresponding author
- Pala, L.
- Venue
- Acta Diabetologica
- Published
- 2020-08-13
- Volume
- 58
- Issue
- 4
- Pages
- 401-410
- ISSN
- 0940-5429 (ISSN-L)
- 1432-5233
- OpenAlex
- W3049019930
- Cited by
- 106
- References
- 55
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 22 · 2023: 23 · 2022: 25 · 2021: 7
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Acta Diabetologica (publishedVersion)
- PubMed (publishedVersion)
- Florence Research (University of Florence) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 1 diabetes, continuous glucose monitoring, flash glucose monitoring, self-monitoring of blood glucose, glycemic control, HbA1c, severe hypoglycemia, insulin pump therapy, multiple daily insulin injections, time in range, health-related quality of life, treatment satisfaction
- MeSH terms
- Glycemic Control, Adult, Blood Glucose, Computer Systems, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Male, Quality of Life, Blood Glucose Self-Monitoring, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.